CRA Compliance Checklist: Laboratory Instruments & Scientific Equipment
Default to Annex III Class I — laboratory instruments with network connectivity are products with digital elements; analytical instruments in regulated environments may be Class I; IVD-classified instruments are MDR-excluded
Laboratory instruments and scientific equipment — including networked analysers, chromatography systems, mass spectrometers, laboratory information management systems (LIMS), and laboratory automation platforms — are products with digital elements subject to the CRA. In Vitro Diagnostic (IVD) instruments regulated under IVDR are excluded from CRA scope. General-purpose laboratory instruments with network connectivity and data management capabilities are fully in CRA scope.
1. Scope & Classification
Verify whether laboratory instruments are classified as IVDs under IVDR 2017/746 — if so, assess whether the IVDR provides equivalent coverage for CRA exclusion
IVD instruments regulated and compliant under IVDR are generally excluded from CRA scope. General-purpose laboratory instruments (HPLC, GC-MS, spectrophotometers) without an IVD intended purpose are fully in CRA scope.
Assess Annex III Class I for laboratory instruments in regulated quality-critical environments (pharmaceutical GMP, forensic labs, environmental monitoring)
Laboratory instruments providing data used in pharmaceutical batch release, forensic evidence, or environmental regulatory reporting may be important products warranting Class I.
Assess LIMS and laboratory automation software as standalone software products with digital elements — fully in CRA scope regardless of hardware classification
LIMS software, laboratory automation platforms, and electronic lab notebooks (ELNs) are standalone software products in CRA scope. Each requires its own CVD policy, SBOM, and DoC.
Compile SBOM for instrument firmware, control software, data acquisition software, and laboratory integration middleware
Laboratory instruments include embedded firmware, Windows-based control software, and laboratory data system (LDS) software. Compile SBOMs for each software layer.
2. Product Security (Annex I Part I)
Implement role-based access control for laboratory instruments — separate operator, scientist, administrator, and service roles
Laboratory instruments processing regulated data require strict access controls. In GMP environments, audit trails and access controls are also regulatory requirements (21 CFR Part 11 / EU Annex 11).
Implement tamper-evident audit trails for all instrument data — align with FDA 21 CFR Part 11 and EU Annex 11 requirements for electronic records
21 CFR Part 11 and EU Annex 11 require audit trails for electronic records in regulated environments. CRA Part I(8) logging requirements align with these. Implement compliant audit trails that satisfy both.
Encrypt all instrument data transmissions — chromatography data, analytical results, and calibration records must be protected in transit
Laboratory data transmitted over lab networks should be encrypted. Use TLS for all data transfers between instruments, LIMS, and data repositories.
Implement cryptographically signed software updates — laboratory instrument software updates must be verified before installation in regulated environments
Software updates to instruments in regulated laboratories require validation. Signed updates support change control processes by allowing integrity verification before and after update.
3. CVD Policy & Vulnerability Handling
Publish a CVD policy and security contact for laboratory instrument software vulnerabilities
Laboratory instrument software, particularly Windows-based data systems, faces the same vulnerability landscape as general Windows applications. A CVD policy enables responsible disclosure.
Align security patch delivery with laboratory change control processes — provide validated patches with qualification documentation
In GMP laboratories, software changes require validation. Provide security patches with IQ/OQ/PQ documentation to support customers' change control processes and reduce the validation burden.
Define security support lifecycle appropriate to laboratory equipment investment cycles — minimum 7 years
Laboratory instruments are capital investments with 7–15 year lifespans. Publish per-product security support end dates and provide migration guidance before end of support.
4. Article 14 Incident Reporting
Define Article 14 triggers — focus on data integrity compromise in regulated quality systems, exfiltration of proprietary research data, and ransomware disrupting laboratory operations
Exploitation compromising the integrity of GMP quality data or research data supporting regulatory submissions is a significant Article 14 trigger.
Coordinate Article 14 reporting with GDPR breach notifications if laboratory instruments process personal data (e.g. patient samples in clinical labs)
Clinical laboratory instruments processing patient samples handle personal data. A breach may trigger both CRA Article 14 and GDPR Article 33.
5. CE Marking & Technical Documentation
For IVD-excluded instruments, maintain IVDR technical documentation as primary compliance evidence and confirm MDR/IVDR exclusion applies
IVD instruments require active IVDR compliance to benefit from CRA exclusion. Ensure your IVDR technical file and Notified Body assessment are current.
For non-IVDR laboratory instruments, prepare CRA technical file and issue EU Declaration of Conformity
Non-IVD laboratory instruments require full CRA DoC and technical file. Leverage 21 CFR Part 11 / EU Annex 11 validation documentation as supplementary evidence.
Track your Laboratory Instruments & Scientific Equipment compliance progress in CVD Portal.
Public CVD submission portal, Article 14 deadline alerts, SBOM tracking, and CSAF advisory generation. Free forever for manufacturers.
Start your free portalFrequently asked
Our analytical instruments run Windows 10 with vendor-specific data acquisition software — does the Windows support lifecycle affect our CRA obligations?+
Yes. CRA requires you to deliver security updates for the duration of your stated support period. If your instruments run Windows 10, which reaches end of mainstream support in October 2025, you must obtain Extended Security Updates (ESU) from Microsoft, upgrade the OS, or implement compensating controls. You cannot meet your CRA security update obligations for OS-level vulnerabilities on an unsupported OS. Plan your OS migration strategy now.
We manufacture laboratory equipment that is used in both research and clinical settings — does the clinical use change the CRA classification?+
The CRA classification is based on the product's design and intended use. If you market the same instrument for both research and clinical use, the clinical use implications may support a higher classification. If the instrument can be used in IVD applications in clinical settings, consult with a Notified Body about IVDR classification. The IVDR exclusion would only apply if the instrument is actually IVDR-compliant for its clinical use.
Our LIMS is deployed in a pharmaceutical GMP environment — do 21 CFR Part 11 / EU Annex 11 compliance and CRA have significant overlap?+
Yes, there is significant overlap. Both frameworks require: audit trails (CRA Part I(8) / 21 CFR 11.10(e)), access controls (CRA Part I(2) / 21 CFR 11.10(d)), system validation documentation (CRA technical file / 21 CFR 11.10(a)), and software change control (CRA update requirements / 21 CFR 11.10(k)). Design your compliance programme to satisfy both simultaneously. Your LIMS validation documentation can provide substantial CRA technical file evidence.
Need a CVD policy for Laboratory Instruments & Scientific Equipment?
Download a free CRA-compliant disclosure policy template and deploy it in minutes.